Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the 14 Best S&P 500 Stocks to Buy Now, with analysts giving it a consensus Strong Buy rating and a one-year average share price target of $640.30, indicating a 12% upside potential from current levels.

Wells Fargo raised its price target on TMO to $675 from $635, citing clarity on government policies and future growth projections. The firm maintains an Overweight rating on the stock, believing it is well-positioned for growth in the tools and equipment sector.

Citigroup upgraded TMO to Buy from Neutral and increased its price target to $660 from $580, citing positive trends in the tools and diagnostics segment. Analysts believe the company will benefit from ongoing onshoring trends and increased pharmaceutical spending.

Thermo Fisher Scientific Inc. (NYSE:TMO) is a key player in life sciences solutions, laboratory products, diagnostics, analytical instruments, and biopharma services. The stock has seen a modest 8% gain in 2025, making it an attractive investment option for those interested in the sector.

While TMO shows promise as an investment, some AI stocks may offer greater upside potential with less downside risk. Investors seeking undervalued AI stocks poised to benefit from current trends can explore opportunities highlighted in a free report on the best short-term AI stock.

Read more at Yahoo Finance: Analysts See 12% Upside To Thermo Fisher Scientific Inc. (TMO)